Table 1. Baseline data of 24 patients before diagnosis of BKVN.
| Total (n=24) | |
|---|---|
| Male gender, n (%) | 18 (75.0%) |
| Age at transplant (years), n (%) | 37.5 (31.3–45.4) |
| Body weight (kg) | 51.5 (50.0–57.0) |
| ESRD etiology, n (%) | |
| Glomerulonephritis | 14 (58.3%) |
| IgA nephrology | 6 (25.0%) |
| Hypertensive nephropathy | 2 (8.3%) |
| Nephrotic syndrome | 1 (4.2%) |
| Lupus nephritis | 1 (4.2%) |
| Induction regimen, n (%) | |
| Polyclonal antibody/ATG | 12 (50.0%) |
| Monoclonal antibody/Basiliximab | 12 (50.0%) |
| Maintenance regimen, n (%) | |
| Tacrolimus-MPA-Steroid | 24 (100%) |
| MPA-AUC (ng/ml) | 68.0 ± 30.2 |
| Transplant donor type, n (%) | |
| Deceased | 17 (70.8%) |
| Living | 7 (29.2%) |
Abbreviations: ATG, antithymocyte globulin; MPA-AUC, MPA concentration-area under curve.